Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Positive crawled time : 14:20 save search
Continued Positive Performance of Novel Drug Development by Annovis Bio Presented at 2023 Alzheimer's Association International Conference
Published: 2023-07-18 (Crawled : 14:20) - biospace.com/
ANVS | $10.09 2.44% -0.15% 220K
|
Health Technology
|
| O: 1.63%
H: 1.99%
C: 0.36%
drug conference association positive international alzheimer's
Early Feedback is Positive as Holland America Line Installs SpaceX's Starlink on First Ship in Alaska
Published: 2023-05-16 (Crawled : 14:20) - prnewswire.com
CUK | News 0 d | $12.73 -0.55% -0.47% 1.1M
|
Consumer Services
|
| O: -1.09%
H: 4.26%
C: 1.65%
CCL | News 0 d | $14.12 -0.42% 0.0% 29M
|
Consumer Services
|
| O: -0.48%
H: 3.7%
C: 0.97%
america positive
PainReform Announces Positive Safety Data in First Part of Phase 3 Clinical Trial of PRF-110 in Patients Undergoing Bunionectomy Surgery
Published: 2023-05-01 (Crawled : 14:20) - globenewswire.com
PRFX 1 d | $0.8737 -1.83% -1.87% 29K
|
Health Technology
|
| O: 17.2%
H: 8.7%
C: -0.15%
prf-110 positive
Zentalis to present positive clinical data in ovarian cancer combining azenosertib and chemotherapy, including clinical support for Cyclin E1 expression as predictive marker for clinical benefit from azenosertib at the 2023 ASCO Annual Meeting
Published: 2023-04-26 (Crawled : 14:20) - globenewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -4.57%
H: 0.22%
C: -1.98%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.03%
H: 0.3%
C: -2.63%
ZNTL | $12.97 3.43% 3.32% 1M
|
Health Technology
|
| O: -0.23%
H: 0.18%
C: -1.43%
asco positive cancer meeting
Nexcella Announces New Positive NXC-201 Clinical Data Demonstrating 100% Complete Responses in AL Amyloidosis Patients
Published: 2023-03-23 (Crawled : 14:20) - biospace.com/
IMMX | $2.21 0.0% 64K
|
|
| O: 0.93%
H: 3.06%
C: -8.8%
nxc-201 positive
Altimmune Announces Positive Results from Week 24 Interim Analysis of Pemvidutide MOMENTUM Phase 2 Obesity Trial and 12-Week Phase 1b Type 2 Diabetes Safety Trial
Published: 2023-03-21 (Crawled : 14:20) - biospace.com/
ALT | $6.91 0.29% 0.29% 3.6M
|
Commercial Services
|
| O: -37.27%
H: 1.31%
C: -27.74%
obesity momentum positive week trial diabetes results
Vir Biotechnology Announces Positive Final Draft Guidance on Sotrovimab from the UK’s National Institute for Health and Care Excellence (NICE)Final draft guidance based on cost effectiveness evaluation of sotrovimab
Published: 2023-02-22 (Crawled : 14:20) - biospace.com/
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: 0.06%
H: 2.11%
C: 0.2%
VIR | $7.96 0.0% 1.1M
|
Health Technology
|
| O: 0.04%
H: 3.96%
C: 0.04%
care health positive
Avrupa Minerals to Continue Positive Progress in Finland, Portugal, and Kosovo in 2023
Published: 2023-02-08 (Crawled : 14:20) - avrupaminerals.com
AVPMF | $0.012 420.0% 18K
|
Miscellaneous
| Email alert
Add to watchlist
positive
Blueprint Medicines to Present Positive Data from PIONEER Trial of AYVAKIT® (avapritinib) in Indolent Systemic Mastocytosis at 2023 AAAAI Annual Meeting
Published: 2023-02-03 (Crawled : 14:20) - prnewswire.com
BPMC | $86.87 -2.28% -2.34% 800K
|
Health Technology
|
| O: -2.06%
H: 2.62%
C: -4.99%
ayvakit meeting trial positive
Cassava Sciences Announces Positive Top-Line Clinical Results in Phase 2 Study Evaluating Simufilam in Alzheimer’s Disease
Published: 2023-01-24 (Crawled : 14:20) - globenewswire.com
SAVA | $19.61 -7.46% -8.06% 1.3M
|
Health Technology
|
| O: -6.97%
H: 1.97%
C: -13.16%
sciences disease alzheimer’s positive results study phase 2
Silver Viper Presents Highly Positive Geophysical and Geochemical Survey Results at La Virginia
Published: 2023-01-12 (Crawled : 14:20) - prnewswire.com
PAAS | $19.07 0.05% -0.47% 4.1M
|
Non-Energy Minerals
|
| O: 1.59%
H: 0.59%
C: -0.22%
positive results
Pulmatrix Announces Positive Top Line Results from a Phase 1 Study with PUR3100, a Novel Orally Inhaled Dihydroergotamine (DHE), for Acute Migraine
Published: 2023-01-04 (Crawled : 14:20) - prnewswire.com
PULM | $2.0 2.04% 2.0% 12K
|
Health Technology
|
| O: -17.61%
H: 13.96%
C: 6.27%
pur3100 migraine positive study phase 1
Panbela Receives Positive EMA Opinion on Orphan Designation for Ivospemin (SBP-101) in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
Published: 2022-12-14 (Crawled : 14:20) - globenewswire.com
PBLA | $0.4895 -6.31% 66K
|
Professional, Scientific, and T...
|
| O: 30.91%
H: 36.67%
C: -33.78%
sbp-101 designation ema gemcitabine positive pancreatic
Femasys Inc. Reports Encouraging Promotional Launch of FemCerv at AAGL Based on Positive Reception by Gynecologic Physicians and Surgeons
Published: 2022-12-12 (Crawled : 14:20) - biospace.com/
FEMY | $1.33 1.53% 1.5% 160K
|
Manufacturing
|
| O: 8.33%
H: 0.0%
C: -7.69%
positive
Longboard Pharmaceuticals Announces Positive Topline Data from a Phase 1 Clinical Study Evaluating Central Nervous System Pharmacokinetics and Pharmacodynamics of LP352 in Healthy Volunteers
Published: 2022-12-05 (Crawled : 14:20) - biospace.com/
LBPH | $17.48 -2.94% -3.03% 520K
|
Manufacturing
|
| O: -3.75%
H: 3.0%
C: -5.0%
lp352 pharmaceuticals system topline positive study phase 1
RedHill Biopharma Announces Positive New Data with Opaganib for Nuclear Radiation Injury
Published: 2022-11-17 (Crawled : 14:20) - biospace.com/
RDHL | $0.4519 7.39% 6.88% 330K
|
Health Technology
|
| O: 13.43%
H: 0.0%
C: -10.89%
biopharma opaganib nuclear positive
Avenue Therapeutics Completes the Acquisition of Baergic Bio and its Selective GABA-A α2/3 Receptor Positive Allosteric Modulator for the Treatment of Central Nervous System Disorders
Published: 2022-11-08 (Crawled : 14:20) - biospace.com/
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 2.49%
H: 0.0%
C: -1.6%
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: 0.0%
H: 4.76%
C: -4.6%
ATXI | $0.1295 -3.79% -3.94% 320K
|
Health Technology
|
| O: 7.78%
H: 6.67%
C: -7.78%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.2%
H: 0.96%
C: 0.18%
treatment acquisition system therapeutics positive
Actinium Announces Positive 1-Year and 2-Year Overall Survival Data for Patients with Relapsed or Refractory AML in Phase 1 Actimab-A CLAG-M Combination Trial
Published: 2022-11-03 (Crawled : 14:20) - biospace.com/
ATNM | $6.85 2.7% 0.0% 350K
|
Health Technology
|
| O: 0.42%
H: 4.49%
C: -11.82%
aml trial positive phase 1
HOTH THERAPEUTICS REPORTS POSITIVE BIOLEXA PHASE 1B CLINICAL TRIAL RESULTS IN MILD TO MODERATE ATOPIC DERMATITIS
Published: 2022-10-31 (Crawled : 14:20) - prnewswire.com
HOTH | $1.22 3.39% 3.28% 22K
|
Health Technology
|
| O: -0.44%
H: 39.57%
C: -1.06%
dermatitis trial therapeutics positive results phase 2b
Timber Pharmaceuticals Receives Positive Opinion on Orphan Designation from European Medicines Agency for TMB-001 for Treatment of Autosomal Recessive Congenital Ichthyosis
Published: 2022-09-14 (Crawled : 14:20) - biospace.com/
TMBR | $0.3426 -2.69% 3K
|
Health Technology
|
| O: 5.69%
H: 34.23%
C: 7.31%
tmb-001 treatment designation positive
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.